Aldesleukin Completed Phase 1 Trials for Metastatic Cancers / Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00027807Biological Therapy in Treating Women With Stage IV Breast Cancer
NCT00301730Cellular Adoptive Immunotherapy in Treating a Patient Who Has Undergone a Donor Stem Cell Transplant for Breast Cancer That Has Spread to the Lung